Viewing Study NCT00452569


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-04 @ 5:11 PM
Study NCT ID: NCT00452569
Status: COMPLETED
Last Update Posted: 2019-11-18
First Post: 2007-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module